North Asia buyout player MBK sells GP stake to Dyal
North Asia-focused buyout firm MBK Partners has sold a 12% GP stake to Dyal Capital Partners, a unit of US-based alternative investment firm Blue Owl that buys interests in third-party managers.
The development was first reported by Bloomberg and has since been confirmed to AVCJ by a source close to the situation. While Bloomberg claimed that Dyal had acquired “roughly 13%” of MBK’s management...
More on GPs
Latest News
Hong Kong's Animoca raises $359m at $5b valuation
US-based Liberty City Ventures has led a USD 359m round for Hong Kong blockchain media company Animoca Brands at a pre-money valuation of USD 5bn, more than double its valuation in October.
China beauty retailer Harmay raises $200m
Harmay, a China-based omnichannel beauty products retailer, has raised USD 200m across Series C and D rounds.
TPG-owned clinical trials player raises new equity, debt
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
Quadrant exits Australia experiential tourism business
Quadrant Private Equity has sold Journey Beyond, an Australia-based experiential tourism business, to US-based Hornblower Group, which is best known for offering cruise and sightseeing packages.